Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/AIM-IMMUNOTECH-INC-65218228/news/Aim-Immunotech-Reports-Positive-Topline-Results-from-Phase-2-Study-Evaluating-Ampligen-for-the-Treat-45915072/?utm_source=whatsapp&utm_medium=social&utm_campaign=share